Moreover, the HDAC6 inhibitor treatment of DLBCL and B-cell lymphoma cells in Eμ-Myc mice induced MYC degradation, apoptosis, and inhibition of lymphomagenesis [189]. This evidence concerns the gene HDAC6 and diffuse large B-cell lymphoma.